Milan, Italy (August 27, 2024)

Today, MgShell, a MedTech company that aspires to inspire a change in ophthalmology by developing a magnesium-based drug delivery platform capable of reshaping patient care and enhancing treatment adherence for patients suffering from retinal diseases, announced its victory in the Startup of the Year category of the South Europe Startup Awards (SESA) and its nomination as finalist of the Global Startup Awards.

The final event will be held September 25, 2024 in Istanbul, Turkey.

Every year, the Global Startup Awards source the very best startups, most influential individuals and ecosystem players to find the very best technology companies and the talented entrepreneurs behind them.

About MgShell:

MgShell, headquartered in Milan, Italy, is a preclinical-stage drug delivery company focused on developing a magnesium-based drug delivery platform capable of reshaping patient care, enhancing treatment adherence for patients suffering from retinal diseases, and lowering healthcare expenses.